Research Article
Pentraxin 3 Plasma Levels and Disease Activity in Systemic Lupus Erythematosus
Table 1
Characteristics of SLE patients and healthy controls.
| | | SLE patients () | Healthy controls () | value |
| | Clinical features | | | | | Age (years) |
46.8 ± 15.1 | 41.8 ± 12.6 | 0.801 | | Sex (% of women) | 87.5 | 90 | 0.84 | | Systolic blood pressure (mmHg) | 120 ± 18 | 114 ± 12 | 0.63 | | Diastolic blood pressure (mmHg) | 72 ± 13 | 70 ± 12 | 0.54 | | Clinical manifestations | | | | | Renal involvement | 23.4 |
— | NA | | Seizure | 6.2 | — | NA | | Severe headache | 4.6 | — | NA | | Myositis | 4.6 | — | NA | | Arthritis | 34.3 | — | NA | | Malar rash/alopecia | 12.5 | — | NA | | APS | 18.4 | — | NA | | Retinal vasculitis | 1.5 | — | NA | | Anemia | 48.4 | — | NA | | Lymphopenia | 40 | — | NA | | Leukopenia | 11 | — | NA | | Thrombocytopenia | 15.6 | — | NA | | Laboratory parameters | | | | | Total cholesterol (mg/dL) | 188 ± 75 | 193 ± 27 | 0.57 | | HDL-cholesterol (mg/dL) | 48 ± 9 | 53 ± 4 | 0.54 | | LDL-cholesterol | 95 ± 2 | 98 ± 3 | 0.91 | | Triglycerides (mg/dL) | 49 ± 18 | 54 ± 11 | 0.54 | | Serum iron (μg/mL) | 91 ± 14 | 98 ± 12 | <0.05 | | Hemoglobin (g/dL) | 8 ± 2 | 9.4 ± 4 | <0.05 | | C3 (mg/L) | 82.5 ± 32.1 | 102.5 ± 52 | <0.05 | | C4 (mg/L) | 13.1 ± 6.7 | 31 ± 12.1 | <0.05 | | Anti-dsDNA (IU/mL) | 814 ± 461 | 1 ± 0.2 | <0.05 | | Serum creatinine (mg/dL) | 1.2 ± 0.9 | 0.97 ± 0.2 | <0.05 | | Serum albumin (g/dL) | 2.8 ± 0.7 | 4.1 ± 0.4 | <0.05 | | Inflammatory marker | | | | | Erythrocyte sedimentation rate (mm/h) | 58 ± 40 | 10 ± 12 | <0.05 |
|
|
